CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −7,000 | $1.50 | $11K | 1,980,358 |
| 2022-11-09 | JORDEN DAVID EMERSON CEO/CFO | Sale | −5,000 | $1.50 | $8K | 1,975,358 |
| 2022-06-06 | CLAUSEN PETER CSO/COO | Grant or award · Option to Purchase Common Stock | +275,000 | 275,000 | ||
| 2022-04-29 | JORDEN DAVID EMERSON CEO/CFO | Grant or award | +10,532 | $1.00 | $11K | 2,137,858 |
| 2022-04-29 | CLAUSEN PETER CSO/COO | Grant or award | +25,000 | $1.00 | $25K | 526,201 |
| 2022-04-29 | Pittman Scott M. Director | Grant or award | +100,000 | $1.00 | $100K | 4,343,345 |
| 2022-04-29 | SHEEDY CHARLES E 10% owner | Purchase | +804,868 | $1.00 | $805K | 11,000,000 |
| 2022-03-04 | Pittman Scott M. Director | Option exercise · Option to Purchase Common Stock | −33,334 | 0 | ||
| 2022-03-04 | Mintz Paul Director | Grant or award · Option to Purchase Common Stock | +26,666 | 26,666 | ||
| 2022-03-04 | Mintz Paul Director | Grant or award · Option to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-03-04 | WINZER C ERIC Director | Grant or award · Option to Purchase Common Stock | +36,666 | 36,666 | ||
| 2022-03-04 | WINZER C ERIC Director | Grant or award · Option to Purchase Common Stock | +75,000 | 75,000 | ||
| 2022-03-04 | CLAUSEN PETER CSO/COO | Grant or award · Option to Purchase Common Stock | +43,328 | 43,328 | ||
| 2022-03-04 | Pittman Scott M. Director | Grant or award · Option to Purchase Common Stock | +33,334 | 33,334 | ||
| 2022-03-04 | Pittman Scott M. Director | Grant or award · Option to Purchase Common Stock | +100,000 | 100,000 | ||
| 2022-03-04 | JORDEN DAVID EMERSON CEO/CFO | Grant or award · Option to Purchase Common Stock | +66,672 | 66,672 | ||
| 2022-03-04 | JORDEN DAVID EMERSON CEO/CFO | Grant or award · Option to Purchase Common Stock | +125,000 | 125,000 | ||
| 2019-01-01 | JORDEN DAVID EMERSON CEO, CFO | Grant or award · Option to Purchase Common Stock | +125,000 | 125,000 | ||
| 2018-12-31 | JORDEN DAVID EMERSON CEO/CFO | Option exercise · Option to purchase common stock | −125,000 | 0 | ||
| 2018-12-31 | Mintz Paul Director | Option exercise · Option to purchase common stock | −50,000 | 0 |
Page 5 of 17 · 326 trades